muscimol has been researched along with sch 23390 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO | 1 |
| Cazala, P; David, V; Decorte, L; Gavello-Baudy, S; Le Merrer, J | 1 |
| Floresco, SB; Winstanley, CA; Zeeb, FD | 1 |
| Bai, Y; Chen, L; Chi, X; Li, L; Sokabe, M; Yang, R; Zhou, R; Zhu, Y | 1 |
| Moore, T; Noudoost, B | 1 |
| Nazari-Serenjeh, F; Rezayof, A; Zarrindast, MR | 1 |
| Abela, AR; Chudasama, Y | 1 |
| Kokare, DM; Kumar, S; Shelkar, GP; Singru, PS; Subhedar, NK | 1 |
| Moncada, D | 1 |
| Berridge, CW; Spencer, RC | 1 |
10 other study(ies) available for muscimol and sch 23390
| Article | Year |
|---|---|
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles | 2005 |
Self-administration of the GABAA agonist muscimol into the medial septum: dependence on dopaminergic mechanisms.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bicuculline; Data Interpretation, Statistical; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Injections, Intraventricular; Male; Mice; Mice, Inbred BALB C; Microinjections; Muscimol; Nucleus Accumbens; Photomicrography; Receptors, Dopamine D1; Reinforcement Schedule; Self Administration; Septal Nuclei; Sulpiride; Ventral Tegmental Area; Vestibular Nuclei | 2008 |
Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues.
Topics: Analysis of Variance; Animals; Baclofen; Benzazepines; Choice Behavior; Conditioning, Operant; Cues; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; GABA Agonists; Impulsive Behavior; Male; Muscimol; Prefrontal Cortex; Rats; Rats, Long-Evans; Reinforcement Schedule; Reward; Salicylamides; Signal Transduction | 2010 |
Abnormal synaptic plasticity in basolateral amygdala may account for hyperactivity and attention-deficit in male rat exposed perinatally to low-dose bisphenol-A.
Topics: Air Pollutants, Occupational; Amygdala; Animals; Attention Deficit Disorder with Hyperactivity; Benzazepines; Benzhydryl Compounds; Bicuculline; Disease Models, Animal; Dizocilpine Maleate; Dopamine Antagonists; Female; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Glutamate Decarboxylase; Long-Term Potentiation; Male; Muscimol; Neuronal Plasticity; Phenols; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2011 |
Control of visual cortical signals by prefrontal dopamine.
Topics: Animals; Benzazepines; Dopamine; GABA-A Receptor Agonists; Macaca mulatta; Muscimol; Neurons; Prefrontal Cortex; Receptors, Dopamine D1; Saccades; Visual Cortex; Visual Perception | 2011 |
Functional correlation between GABAergic and dopaminergic systems of dorsal hippocampus and ventral tegmental area in passive avoidance learning in rats.
Topics: Amnesia; Animals; Avoidance Learning; Benzazepines; Dopamine Antagonists; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Interactions; GABA-A Receptor Agonists; GABAergic Neurons; Hippocampus; Male; Mental Recall; Microinjections; Muscimol; Rats; Rats, Wistar; Sulpiride; Ventral Tegmental Area | 2011 |
Noradrenergic α2A-receptor stimulation in the ventral hippocampus reduces impulsive decision-making.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Baclofen; Benzazepines; Conditioning, Operant; Delay Discounting; Dopamine Antagonists; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; GABA-B Receptor Agonists; Guanfacine; Hippocampus; Impulsive Behavior; Male; Muscimol; Rats, Long-Evans; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1; Receptors, GABA-A; Receptors, GABA-B; Reward; Time Factors | 2014 |
Noradrenergic inputs from locus coeruleus to posterior ventral tegmental area are essential to support ethanol reinforcement.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Adrenergic Agents; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic Neurons; Anesthetics, Local; Animals; Behavior, Animal; Benzazepines; Benzylamines; Central Nervous System Depressants; Conditioning, Operant; Disulfiram; Dopamine Antagonists; Ethanol; GABA-A Receptor Agonists; Lidocaine; Locus Coeruleus; Male; Muscimol; Phenylephrine; Prazosin; Rats; Rats, Wistar; Receptors, Dopamine D1; Reinforcement, Psychology; Reward; Self Administration; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2017 |
Evidence of VTA and LC control of protein synthesis required for the behavioral tagging process.
Topics: Adrenergic beta-Antagonists; Animals; Anisomycin; Avoidance Learning; Behavior, Animal; Benzazepines; Dopamine Antagonists; GABA-A Receptor Agonists; Locus Coeruleus; Male; Memory; Memory Consolidation; Muscimol; Neurons; Propranolol; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Recognition, Psychology; Ventral Tegmental Area | 2017 |
Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Attention; Benzazepines; Central Nervous System Stimulants; Cognition; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Imidazoles; Male; Memory, Short-Term; Methylphenidate; Muscimol; Neostriatum; Neural Pathways; Oxathiins; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1 | 2019 |